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Abstract
Synergistic Action of the Synaptotagmin Family in Neurotransmitter Release
Ekaterina M Stroeva
2021
The overarching theme of my thesis work is centered around the understanding of how
the Synaptotagmin (Syt) family of proteins, which are key players in neurotransmission,
is regulated in the brain. Upon very briefly introducing other key molecular players,
firstly, I summarize the discovery of the regulation of Syts by self-oligomerization. This
work is focused on the characterization of the physiologically relevant Syt1 ring-like
oligomers, which are formed in the presence of negatively charged lipids and dissociate
upon calcium binding. Using the approach of hypothetical structure-guided mutagenesis,
phenylalanine in position 349 is identified as critical for the oligomer formation.
Importantly, an alanine mutation in this position abolishes the oligomer formation, while
no other molecular properties are affected (which I established using a variety of
biochemical and biophysical techniques). Taken together, we hypothesize that the
oligomer can act as a “stopper” of spontaneous fusion between the opposing membranes;
yet it also acts to synchronize the arrival of action potential to the evoked vesicular fusion
and neurotransmitter release. In addition, the relevance of the Syt1 oligomers is shown in
model cell cultures and the hypothesis is further refined using other structural and in vitro
reconstitution approaches.
A family of Synaptotagmins (Syts) undergo several types of post-translational
processing, which regulates neuronal growth and plasticity. Protein kinase C (PKC),

which is highly, yet differentially expressed in the brain, has been previously shown to
potentiate synaptic vesicle release via phosphorylation of the Syt1 isoform. However, the
precise mechanism and functional effect of phosphorylation on Syt1 function remains
unclear. In this work, we identified a new site of phosphorylation (T328/T329), located
within the polybasic patch of the C2B domain which is functionally important for binding
to PIP2 and other negative lipid headgroups. To study the effect of phosphorylation at
this site, we introduced a phospho-mimetic amino acid substitution (Syt1T328/329E). We
used a single-vesicle fusion assay to monitor the docking, clamping, fusion, and release
of a single vesicle. This fluorescence-based assay tracks individual v-SNARE containing
vesicles (vSUVs) as they approach the physiologically relevant mimic of the target
membrane. vSUVs containing 24 copies of wild-type Syt1 (Syt1WT) and 12 copies of
VAMP2 remain stably docked and fuse after addition of 1 mM calcium ions. To the
contrary, Syt1T328/329E containing vSUVs abolished clamping ability thereby leading to
spontaneous fusion. The role of phosphorylation of Syt1 by PKC was further
corroborated by a γ-32P radiography-based protocol for the in vitro phosphorylation of
Syt1WT-containing vSUVs. Phosphorylated vesicles recapitulated the loss-of-clamping
behavior exhibited by the Syt1T328/329E -containing vesicles. Expectedly, phosphorylated
Syt1 exhibited a dramatic reduction in its ability to bind negatively charged membrane in
the basal (EDTA/Mg2+) state and in the presence of physiologically relevant calcium
concentrations. As PIP2 binding is crucial for Syt1 to oligomerize and clamp vesicle
fusion, we posit that phosphorylation of Syt1 at residue 328/329 abrogates clamping
function by disrupting the ability of Syt1 to oligomerize. Our findings suggest a novel
mechanism of in situ regulation of Syt1 function by PKC.
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CHAPTER 1
INTRODUCING THE KEY PLAYERS OF NEUROTRANSMITTER RELEASE

1.1 Bird’s eye view of neurons and neurotransmission
The neuron is a specialized cell that transmits information to other nerve, muscle, and
secretory cells. The axon of one neuron sends messages to the dendrites (and bodies) of
other neurons (or other cells). In the case of a chemical synapse, signals propagate from
one neuron to another via small molecules. These neurotransmitters are enclosed in
membrane sacks, called synaptic vesicles. Vesicular lifetime and recycling are very
tightly regulated by the synaptic machinery and other signaling cascades (Figure 1).

Figure 1: Simplified schematic of a neuronal signaling.
Axons from one neuron send messages to the dendrites of other neurons. Signals
propagate from one neuron to another via neurotransmitters. Illustration is adapted1.
Lipid membrane surrounding the neuronal cells acts as a barrier and a difference in ion
concentration is created across the membrane. The electrical signals propagate along the
neuron and once a sufficient signal is generated, the action potential is created. This
triggers voltage-gated calcium channels to open, allowing calcium ions to flow inside the
cells. Rapidly rising calcium concentration is sensed by the protein machinery, which
then undergoes rapid reorganization, and the neurotransmitter-filled vesicles then proceed
15

to fuse with the presynaptic membrane. The vesicular contents get released into the
opening between the two neurons and diffuse across the cleft. On the receiving neuron,
the molecules bind the receptors. These proteins then either allow further travel of the
action potential, begin a biochemical cascade, or trigger a gene expression (Figure 2).

Figure 2: Schematic architecture of a chemical synapse.
Once the electrical signal arrives, the calcium voltage-gated channels open. The vesicles
fuse to the pre-synaptic membrane and their contents are spilled into the synaptic cleft.
Neurotransmitters diffused across the cleft and bind to the receptors on the receiving
neuron. The signal is further transmitted along the post-synaptic neuron or the receiving
cell. Adapted from2.

16

1.2 Molecular machinery of neurotransmission
Neuronal cells signal using electrical current that is generated from ionic gradients across
the membrane. The primary ion concentrations (sodium and potassium) are tightly
regulated by the opening and closing of ion-selective channels. These voltage-gated
channels operate in response to the changes in membrane potential. Proteins that serve as
channels physically move parts of their structure by changing protein conformation,
which happens in response to the concentration of ions inside the cell (meaning the
imbalance of positively and negatively charged ions determine the total voltage across the
membrane). The number of channels open at a given time and the driving force
“pushing” on the ions determines the total electrical current that flows through the
channel. By propagating the channel opening and closing along the axon of the neuronal
cells and, thus, maintaining a certain voltage across the membrane, the cells transmit the
signal at tens of meters per second. This signal is called an action potential3. Once it has
reached the nerve terminal, the calcium voltage-gated channels open, allowing for
calcium influx down its concentration gradient4.
Synaptotagmin 1 is the most studied isoform among the members of the Synaptotagmin
family. Synaptotagmins are thought to be the key calcium sensors in the synapse. The
protein is 421 amino acids long. Amino acids 1 – 58 are part of the lumenal tail facing
inside the vesicle; the transmembrane domain spans the lipid membrane (amino acid 59 –
80) and connects to the tandem C2 folded domains (141 – 421) via the juxtamembrane
linker (81 – 140). The protein has multiple functions which are critical for the
neurotransmitter release: calcium sensing and membrane binding (Figure 3). One
molecule of Syt1 binds five calcium ions with high micromolar range affinities.
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Synaptotagmin’s transmembrane domain is inserted into the synaptic vesicle bilayer,
while C2A and C2B domains are free to reach and interact with the plasma membrane5.
Presynaptic plasma membrane contains a variety of negatively charged lipids most
notably containing phosphatidylserine and phosphatidylinositol 4,5-bisphosphate6. The
electrostatic interactions between the lipid headgroups and the protein domains
(particularly positively charged stretches on Syt1 C2 domains) are key to tethering
synaptic vesicles on the plasma membrane. Synaptic vesicles also carry a vesicle
associated SNARE protein (Vamp2). On the target plasma membrane, there are other
SNARE motif containing proteins (t-SNAREs). Once these proteins are brought close
enough, the coiled-coil part of each of these spontaneously zipper, which is an incredibly
energetically favorable process7. Zippering of the SNAREs brings the membranes in
close to allow fusion and subsequent release of neurotransmitters. These molecules then
bind to the receptors on the post-synaptic membrane and the signal transduction pathway
continues.

Figure 3: Synaptotagmin 1
domain architecture.
C2A and C2B domains are
globular C2 domains, with the
fold similar to Protein Kinase C
and calmodulin. The C2A and B
domains possess membrane and
calcium binding properties.
Hence, the Synaptotamin
molecule, which is commonly
located in the synaptic vesicles,
can interact with the membrane
in a calcium dependent manner.
Figure is adapted 3.

18

CHAPTER 2
SYNAPTOTAGMIN OLIGOMERIZATION REGULATES VESICLE FUSION:
CURRENT VIEW OF ULTRAFAST NEUROTRANSMITTER RELEASE

2.1 Ring-like oligomers and literature overview
When I joined the lab of Dr. James E. Rothman in 2016, the central hypothesis was that
synaptic transmission is regulated and facilitated by oligomeric structures formed by
Synaptotagmin (Syt) molecules. In addition to the widely studied Syt1 isoform, the
circular oligomeric property was discovered to be a feature of other Syt isoforms (Syt2,
Syt7 and Syt9) and other Syt-like proteins such as Doc2B and extended Synaptotagmin.
Moreover, the oligomers are calcium sensitive, as the calcium-triggered membrane
insertion of Syt1 C2B domain disrupts the ring geometry8 (Figure 4; this work was
performed before I joined the lab and the reports were published in 2014, 2016 and
2017). Thus, we set out to understand the functions and precise arrangement of the
individual subunits in the oligomer. To systematically test the oligomeric structure, we
employed a site-directed mutagenesis approach guided by the preliminary helical
reconstruction (Figure 5). As a rotation student in the lab, I had the wonderful pleasure
working with a post-doctoral researcher Dr. Oscar Bello, who was the leading author on
the study and served as my mentor. Dr. Shyam Krishnakumar soon took over the
mentorship role and under his exceptional guidance, my part of the project was designed
and used as my training ground in a variety of biochemical, biophysical, and structural
techniques
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Thus, this section will summarize the state of the field regarding the hypothesis of Syt1
forming ring-like oligomers, functional implications of the oligomers and specifically my
contributions to the projects in the lab.
In the nineties of the previous century, the scientists noted that Syt1 possessed a curious
capability of forming dimers and higher order oligomers9. The presence of C2 domains
and protein folds in the family of protein kinase C and calmodulin strongly suggested that
Syt isoforms were likely also calcium sensitive10. In the early 2000, the cytosolic domain
of Syt1 was first visualized on lipid monolayers containing phosphatidylcholine and
phosphoserine lipid head groups. Reporting structures were ~11 nm in diameter and were
thought to contain approximately seven subunits11. One key issue with the study was that
their lipid layer mimic did not include polyanionic phospholipid phosphatidylinositol 4,5bisphosphate (PIP2) molecules. Around that time, it was also revealed that PIP2 was
enriched in the presynaptic plasma membrane, yet it was generally not present in the
vesicular membranes12. This lipid molecule is known to serve a few critical roles 1, such

as being processed as a precursor for the second messengers (such as diacylglycerol) and
for the calcium-dependent binding of proteins (such as Protein Kinase C and Syt1)13.
Importantly, a forty-fold increase in calcium sensitivity of Syt1 was observed in the
presence of PIP214.

The class of Phosphatidylinositol molecules and their contribution to the signaling
pathway of Protein Kinase C in neurons is also discussed in Chapter 3 and Figure 14.
1
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Figure 4: Syt1 forms ring-like oligomers under physiologically relevant conditions.
Negative stain electron microscopy analysis of ring-like oligomers formed by the
cytoplasmic domain of Syt1 on lipid monolayers with PS/PIP2 (shown here, A) or in
solution (ATP/Mg2+) under physiological lipid and buffer conditions. Shown in panel B,
the oligomeric structures have an average outer diameter of 30 ± 5 nm, which
corresponds to 15-20 molecules of Syt1. Later it was also shown that the circular
oligomerization property was conserved among other C2-domain containing proteins.
The bottom panel demonstrates that Syt1 ring oligomers are sensitive to Ca2+. A brief 10second treatment of pre-formed rings with Ca2+ in a physiological range (from 0.1 to 1
mM CaCl2) greatly reduced the number of rings observed. This figure is adapted from the
published work8.
Since we were particularly interested in recapitulating the presynaptic plasma membrane
interaction with the Syt1 oligomers and their calcium-dependent dynamics, our electron
microscopy lipid-monolayer studies of Syt1 arrangements included a physiologically
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relevant amount of PIP2 (3-5%). As such, we visualized oligomer sizes of ~30 nm
diameter, which are consistent with ~17 molecules of monomeric Syt1 C2B domains
arranged in a circular fashion. As expected, the structures were responding to
physiologically relevant calcium concentrations as shown in the lower panel of Figure 4.
In a further study, point mutations of the calcium-binding loops in the C2B domain
rendered the ring structures insensitive to calcium8c. While working with lipidmonolayer-Syt1 systems, tubular structures were also observed. Particularly, Syt1
induced formation of lipid tubules via spiraling of the ring-like oligomers around the lipid
layer. The tubes were decorated with oligomeric protein structures and their 3D
arrangements were determined by a helical reconstruction method often used in the field
of crystallography of membrane protein structures15. To further understand the
arrangement of individual monomers of Syt1 in a large order multimer, Syt1 C2AB
purified proteins were allowed to coat and pull the lipid bilayer tubes, which were
deposited on the electron microscopy grid. Acquisition of the diffraction pattern,
followed by the fitting of the C2AB structure onto the parameters of the oligomeric units
on the tube, suggested that the C2B domains were mediating the membrane
interactions16. In addition, the reconstructions suggested that the C2B domain must be
also involved in the multimeric assembly, as C2A would be located further away from
the center (Figure 6). Given the circumference of the lipid tube, the densities of C2A
would not be in close enough proximity. Taking a closer look at the arrangement of the
C2B domains in a circular oligomer, the polybasic patch (K326/327), as expected,
appeared to face the lipid headgroups on the tubular surface (likely contacting the
negatively charged PS and PIP2 groups). As such, the calcium binding loops were situated
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in such a way that they would face into the interface between the subunits. It is then easy
to imagine that since the calcium inserting loops need to turn to contact and embed into
the surface, the oligomeric arrangement of the Syt1 would be incompatible with the
calcium bound state. Thus, this makes sense that the hypothesized oligomers are calcium
sensitive and that they disassemble in the presence of calcium as the oligomer interface
would be disrupted by the conformational change – an approximately ninety-degree flip
in the C2B arrangement towards the membrane and away from the C2B-C2B interface.

2.1.1 Study of Synaptotagmin oligomers by Native Mass Spectrometry
Given that some scientists in the field were originally skeptical of the ring oligomer
hypothesis, we further looked at the oligomeric properties of Syt molecules. A novel
mass spectrometric based technique allowed us to precisely detect different Syt1
multimers formed in solution in their native state. As such, we were able to detect the
relative abundances of the oligomers. In brief, soluble rings were triggered by the
presence of ATP and soluble short-chain PIP2 or IP6 (Inositol hexaphosphate) to mimic
the negative charge normally supplied by the PIP2 headgroups in the membrane. The
samples were then re-equilibrated into the mass spectrometry-compatible buffer
consisting of ammonium acetate and a reducing agent. The resulting representative
spectrum is shown in Figure 5. Note that the abundance of the monomeric species is
higher than the multimeric species. This is likely due to the sub-optimal conditions: the
lack of counter ions like potassium or sodium (which are critical for the overall folding of
C2 domains) and lack of stabilizing negatively charged lipids. We were delighted,
however, to be able to detect the oligomers with a technique orthogonal to electron
microscopy and crystallography. Zooming into the spectrum, we were able to detect up to
23

12-mer containing species. The number of subunits is likely limited by the resolution of
the technique and the chemical equilibrium of the oligomerization reaction.
In fact, we also tested the oligomer formation of Syt7 C2AB and a possibility of a hybrid
oligomer formation. The spectrum of Syt7 is available in Supplement B. Interestingly,
Syt7 was far less likely to produce higher order oligomers. Mostly up to a dimer was
successfully detected above the noise level. This is in direct support of the buttressed ring
hypothesis and the Syt1/Syt7-competing SNARE hypotheses outlined in section 2.4.2. To
our surprise, however, we also noted that Syt1 and Syt7 were prone to forming hybrid
oligomers, which could serve in favor of an alternative (not discussed) hypothesis that
Syt ring oligomers may be composed of C2B domains belonging to different members of
the Synaptotagmin family.
Even though this is still an in vitro assay conducted in far from physiologically relevant
conditions (for example, the studies are ultimately done in the gas phase), the recent
advances in the field of native mass spectrometry and the future developments of nanolipopaprticles derived directly from the bacterial and mammalian cell membranes, will
hopefully help answer many questions on the molecular level to this incredible level of
precision17.
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Figure 5: Native Mass Spectrometric analysis of a WT Syt1 C2AB domain (96 -421).
The purified protein was incubated with oligomer-triggering buffer (1 mM of ATP), exchanged into 20 mM ammonium acetate and 1 mM
DTT, and sprayed on the mass spectrometer. This experiment was performed on the sample that I freshly prepared in the laboratory of Kallol
Gupta at Yale Nanobiology Institute in collaboration with Dr. Fabian Giska and Dr. Aniruddha Panda. Native MS was performed on Q
Exactive UHMR mass spectrometer (Thermo Fisher Scientific) using in-house nano ion-emitting capillaries. The ultrahigh vacuum of 5.65 ×
10−10 mbar, capillary voltage 1.5 kV, optimal insource trapping and HCD were used.
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2.2 Discovery of oligomer-destabilizing mutant F349A
To further investigate the interface between the C2B units, we identified and mutated key
residues that could be employed in the oligomer formation16.

Figure 6: Reconstruction of Syt1-induced lipid bilayer tubes.
Syt1 molecules coat the tube in a spiral manner. The cross-section view (i.e., the view
from the top) suggests that C2B domains are critical in the oligomer formation, while
C2A domains extend out radially.
Hydrophobic residues V304, L307, P310, Y311, Q318, and F349 locating to the Syt1
C2B-C2B dimer interface were non-conservatively mutated to polar asparagine residue.
A conservative mutation to a smaller hydrophobic alanine amino acid was used to probe
the significance of the interactions (Figure 7). Lipid monolayers containing PC/PS and
PIP2 lipid headgroups were created at the water-air interface in a humidity chamber
similar to the protocols commonly used in the membrane protein field18. Briefly, a cavity
in a Teflon block was filled with water to create a convex curvature. A 0.5 µL drop of
lipid mixture was deposited onto the water interface and allowed to form a layer. At this
point is it critical to have the set up in a humidity-controlled environment (a poor man’s
version uses several water-soaked tissues in sealed Tupperware). It is also very important
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to minimize vibrations and movements of the chamber and the Teflon block. Working
quickly and decisively, a glow-discharged carbon-coated EM grid is then used to skim
the surface of the water interface. The resulting layer on top of the grid now has patches
of lipid monolayers. Protein deposition (usually ~5 µM) conditions are optimized to best
suit the quality of imaging. Followed by a series of staining with a freshly prepared
contrast agent (either Uranyl acetate or Uranyl formate) and blotting, the grid is allowed
to completely dry in a dark place over night. The resulting images are then collected
throughout the entire area of the grid, while correcting and discarding break and
imperfection in the monolayers.

Figure 7: Structure-based identification of key residues.
Color-coded residues are: V304, L307, Y311, L394, and F349 in Syt1. Labeled F349 and
L307 exhibited the most profound effect and were further tested biochemically. Helical
reconstruction-based hypothetical arrangement of the Syt1 units in a multimeric structure
reveals possible amino acids involved in the ring formation. The critical residues are in
the C2B domain. C2A domains are not predicted to be critical for oligomer formation.
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2.3 F349A mutation selectively disrupts Syt1 oligomers
This section summarizes work that constituted the core of our paper published in PNAS in
2018 (Bello, O. D.; Jouannot, O.; Chaudhuri, A.; Stroeva, E.; Coleman, J.; Volynski, K.
E.; Rothman, J. E.; Krishnakumar, S. S.). I directly contributed to protein sample
preparation, isolation and purification; I helped with the acquisition and analysis of some
electron microscopy images (section 2.3.1); I was solely responsible for the design,
analysis and aquisiontion of all biophysical and biochemical experiments and replicates
(section 2.3.2 – 2.3.5). I aided in writing the manuscript and making figures.
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2.3.1 Characterization of the ring-disrupting mutants

Figure 8: Effect of the key Syt1 mutants on the ring oligomer formation on the lipid
monolayers.
Both asparagine (polar) and conservative alanine mutations had a profound effect on the
oligomer formation. Y311, L394, and V304 were not statistically critical for the ring-like
structures.
Representative images of the key point mutants affecting oligomerization properties are
shown in Figure 8. Critically, L307A and F349A exhibited drastic effects on the ring
formation. Thus, we set out to test other biochemical properties of the mutants and
compare them back to WT.
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2.3.2 Biochemical analysis of calcium binding

Figure 9: L307A Syt1 mutant binds calcium three times weaker than the WT and
F349A.
Ca2+ binding measured by MST analysis using Alexa Fluor 488-labeled (residue 269)
Syt1 shows that the L307A mutation (blue) lowers the intrinsic Ca2+ affinity but the
F349A mutation (red) has no effect compared with WT (black).
A microscale thermophoresis (MST) technique was used to assess the intrinsic calcium
binding of the C2AB domain of Syt1. This technique was previously used for this exact
purpose by the group of Dr. Reinhard Jahn14. Thus, we first repeated the published results
to validate the method and only then tested out mutants.
Briefly, MST is a powerful, precise, and incredibly sensitive (theoretically, up to
picomolar level concentrations) fluorescence-based technique, which relies on the
difference in the thermophoretic properties of analytes. The directed movement of
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molecules in a temperature gradient (locally induced by an infrared laser to be about 5
degrees) is dependent on shape, molecular weight, charge, hydration shell and
conformational properties. Thus, MST is exceptionally sensitive to the tiniest changes in
molecular properties and can accurately and reliably detect dissociation constants in the
nanomolar range (as tested in our machine)14, 19. MST was measured with ∼50 nM Syt1
(WT, L307A, and F349A) labeled with Alexa Fluor 488 at residue 269 (E269C) in 25

mM Hepes, 100 mM KCl, 2.5 mg/mL BSA, and 0.5% Tween (pH 7.4) using premium
coated capillaries. Figure 9 provides a summary of the calcium binding curves obtained
by MST and normalized to compare the affinity constants. The MST curves were fitted
with simple Michaelis–Menten kinetics to obtain the apparent dissociation constant for
Ca2+ ions.
Clearly, L307A mutant bound calcium ions three-fold weaker than the WT and the
F349A mutant. Thus, we concluded that the L307 residue, though critical for the
oligomer formation, also affected other properties of Syt1. To continue, we focused our
work on F349.
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2.3.3 Biochemical analysis of the SNARE binding

Figure 10: Syt1 WT and the ring-disrupting mutant bind the SNARE complex
similarly.
MST-based experiment titrated the Synaptotagmin1 WT or F349A purified proteins into
the reaction mixtures containing purified and pre-assembled SNARE complex. Premiumcoated capillaries were purchased from NanoTemper Technologies. Addition of BSA and
tween-20 are standard in MST experiments and they are routinely used to prevent surface
adsorption and erroneous precipitation.

Figure 10 above shows that the SNARE interacting properties of Syt1 were not affected
by the F349A mutation. Briefly, the SNARE complex was labelled on VAMP2 cysteine
residue 28 using an Alexa Fluor 488 cysteine-maleimide reaction. The SNARE complex
was formed and purified according to standard protocols. The SNAREs were supplied in
~10 nM concentrations in the presence of the same buffer used for the Ca-binding MST
experiments. Note that for the Syt1–SNARE interaction studies, MST data points beyond
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50 μM Syt1 concentration were not included in the analysis due to precipitation of Syt1
protein at high concentrations under these experimental conditions.

2.3.4 Biochemical analysis of calcium-independent membrane binding
Ca2+-independent Syt1-membrane interaction was measured using a liposome floatation
assay8b, 20. Both Syt1 WT and the ring-disrupting mutant (F349A) bound the negatively
charged membrane in a similar manner. This suggested that the electrostatic interactions
responsible for the membrane binding in the absence of calcium were not affected. Given
that the mutated residue is spatially removed from the polybasic motif (K326/327)
responsible for the interaction with the anionic PIP2 headgroups, it not surprising that the
vesicle docking was not compromised by the F349A mutation.

Figure 11: F349A mutant does not affect calcium-independent membrane binding.
Standard liposome flotation assay was used to probe membrane interaction properties
independent of calcium. Syt1 WT and F349A were incubated with PC/PS/PIP2 liposomes
(71.5% PC, 25% PS, 2.5% PIP2, 1% NBD) for 1 h at room temperature and separated
using a discontinuous Nycodenz (Sigma–Aldrich) gradient. The bound fraction
(normalized to the lipid using NBD fluorescence) was then estimated by densitometry
analysis of SDS/PAGE gels using ImageJ software21.
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2.3.5 Calcium-triggered membrane insertion
To monitor Ca2+-triggered membrane interaction of Syt1 (WT and F349A), the tips of the
calcium-binding loops of the C2B domain (Syt1 residue 304) were labeled with an
environment-sensitive probe, Nitrobenzoxadiazole (NBD). Stopped-flow rapid mixing
analysis was carried out using an Applied Photophysics SX20 instrument22, with the
fluorescently labeled Syt1 pre-incubated with PS/PIP2 liposome (72% PC, 25% PS, 3%
PIP2) loaded in one syringe and buffer containing EGTA or Ca2+ in the other syringe.
The samples were mixed rapidly (dead time ∼ 1 ms), yielding a final concentration of 0.2
mM EGTA and 1 mM Ca2+. The change in fluorescence signal collected with a 510-nm

cutoff filter (Excitation 460 nm) was fitted with a single exponential function to calculate
the observed rate of insertion of the Ca2+ loops.
Stopped-flow analysis is routinely used to measure kinetics of biological processes
occurring on a time scale from seconds to tens of milliseconds23. The time resolution is
mainly dependent on the mixing time of the instrument (also referred to as dead time),
which has been pushed down to 1 millisecond with recent technological advances. To
track the molecular interaction, absorbance and fluorescence are often used as a read-out.
In our case, a fluorescent environmentally sensitive label (7-nitrobenz-2-oxa-1,3-diazol4-yl-ethylenediamine, NBD) was introduced at the tip of the protein loop, which was
thought to penetrate the membrane (residue V304C).
To summarize Figure 12, both Syt1 WT and F349A inserted rapidly into the bilayer
upon Ca2+ binding. EGTA shown in black was used as a control and a baseline condition
in this experiment.
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Figure 12: Calcium triggered membrane insertion is not affected by the mutant.
Ca2+-triggered membrane interaction of the C2B domain was tracked by stopped-flow
rapid mixing analysis with the environment-sensitive fluorescent probe NBD attached to
the C2B-domain residue V304C.
Overall, these in vitro biochemical studies strongly suggested that the F349A mutation
selectively impaired Syt1 oligomerization without affecting other critical molecular
properties. Thus, we set out to test the effect of this key mutant in a cell-based model.

2.3.6 Syt1 oligomeric “clamp” regulates different modes of neurotransmitter
release
PC12 cells are commonly used in neuroscience research. The acronym stands for the rat
adrenal medulla pheochromocytoma line. The model cells exhibit features of exocytosis
similar to that of dopaminergic neurons and have been well characterized for
neurosecretion and neurotransmitter release24.
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For this study, we used an F7 cell line, which is deficient in Syt125. Syt1 WT and the
F349A mutant were expressed in this PC12 cell line. A live-cell total internal reflection
fluorescence microscopy (TIRF) microscopy was used to monitor exocytotic events. A
pHluorin-tag was placed on the luminal portion of VAMP2 (Figure 13). This construct
served as a fusion reporter of vesicles because the pH-sensitive tag changes its
fluorescence signal upon vesicle fusion26. The signal increase upon fusion was then
automatically detected and quantified27.
The over-expression of WT Syt1 rescued the stimulated mode of release in the F7 cells.
Meanwhile, the constitutive mode of release remained low. Strikingly, expression of the
ring-disrupting mutant, F349, exhibited a drastic increase in the amount of spontaneous
exocytosis release. Thus, the evoked and constitutive modes of release were similar in
quantity. This effectively abolished any calcium-control of neurotransmitter release
(Figure 14).

Figure 13: TIRF microscopy set up to measure single exocytotic events in cells.
Individual exocytosis events were assessed by Vamp2-pHluorin TIRF microscopy
imaging of single-vesicle fusion events under basal (constitutive) conditions and after
KCl-induced depolarization (stimulated with Ca2+). Upon fusion, the change in the pH
around the luminal domain of Vamp2, triggers the fluorescence increase, which is then
automatically quantified and compared between the conditions.
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Figure 14: Measuring Single Exocytotic Events in PC12 cells by TIRF microscopy.
Disrupting the Syt1 oligomer dysregulated exocytosis. Drastic increase in the levels of
constitutive exocytosis were observed, thereby effectively abolishing evoked calcium
exocytosis.
Taken together, the data strongly suggested that the ring-like oligomer likely serves as a
suppressor of spontaneous fusion events and essentially couples exocytosis to the arrival
of calcium. Given such a dramatic effect on the exocytosis in a model cell line, we were
now equipped with a mutation that could selectively target and report on the causes and
effects of the Syt1 oligomer formation.
Reflecting on this experience, I am exceptionally grateful to my colleagues for asking me
to contribute to this project. As a result, I was able to master a variety of protein
biochemical and biophysical techniques, starting with recombinant protein isolation,
purification, and characterization to measuring interactions between protein complexes
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and assessing the functionality of protein mutants. In addition to this discovery being
very beneficial for the field overall and our lab in particular, this experience prepared me
well to tackle an independent project also focused around Syt1. Chapter 3 describes how
Protein Kinase C-dependent phosphorylation of Syt1 likely affects its biochemical and
biophysical properties, which I studied using similar in vitro methodology in addition to
other assays available in the laboratory.
The remaining section in this chapter summarizes a few years of research that capitalized
on the discovery of the ring-like oligomer and the F349A mutant.

2.4 Towards functional understanding of a ring-like oligomer.
This section briefly summarizes a few years of research that built on the discovery of the
ring-like oligomer and the F349A mutant. The oligomeric hypothesis was augmented and
reformulated to incorporate the evolving experimental evidence.

2.4.1 F349A mutation abolishes the symmetry under the vesicle
Recent advancements in the Cryogenic Electron Microscopy (Cryo-EM) and the
accessibility of the 300 kV Titan Krios transmission EM equipped with a volta phase
plate allowed my colleagues in the lab to visualize protein arrangements under the
docked vesicle28. In short, NGF-treated PC12 cells were differentiated to increase the
number of small vesicles ~50 nm in diameter (as opposed to the dense core vesicles
normally present in the cells before differentiations). The small vesicles have properties
more closely resembling those of synaptic vesicles. The sections of the cells that appear
after NGF differentiation, protrusions similar to neurites, are thin and thus ideal for cryoelectron tomography. Upon a rigorous 3D class averaging and reconstruction, the authors
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were able to show a symmetrical arrangement of an electron density under the docked
vesicles. Modelling mapped precisely six protein complexes each containing a SNARE
pin, Complexin1, Munc18, and two Syt1 C2B models occupying primary and tripartite
sites of the six-helix SNARE bundle. However, an actual density for a hypothetical Syt1
oligomer was not identified at that limited resolution. Such a symmetrical and precise
arrangement of the proteins limited to exactly six copies must be controlled and
templated by other chaperons. Given that there are many more Vamp2 and t-SNARE
proteins available, it was hypothesized that in addition to Munc13 playing a critical role
in templating, perhaps a Syt1 oligomeric structure is organizing this symmetrical
arrangement. Strikingly, over-expression of the F349A mutant completely abolished the
symmetry, yet some density remained. Given the lack of symmetry and organization
under the docked vesicle, the density was smeared out after rigorous averaging.
Subsequent studies in hippocampal cultured neurons confirmed the hexameric
symmetrical arrangement under the release ready vesicles29. The authors yet again shed
light on the high degree of organization of the protein machinery in primed vesicles under
native conditions in neurons. Even though density that could correspond to the large Syt1
oligomer remained unresolved, given the hypothetical dimensions of the ring, it is easy to
imagine that the highly organized symmetrical arrangement is likely to some extent
templated by the Syt1 molecules acting together.

2.4.2 Hypothetical buttressed rings arrangement
The structural highlights summarized above are in line with the hypothesis that the
SNAREpins get assembled with the help of buttressed rings. The outer ring comprised of
six “banana”-shaped Munc13 MUN domains encompass the inner ring of approximately
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18 Syt C2 domains. Briefly, the Syt1 ring serves as a stabilizing structure of the preassembled SNAREpins. The interaction is via the ‘primary’ SNARE-C2B interface30.
The second layer of C2B domains (which we hypothesize may be comprised of Syt7
C2B) forms an interaction via the ‘tripartite’, complexin-dependent, arrangement31. This
provides a tight vice-like hold of the SNAREs between the two C2B domains and the two
opposing membranes (vesicle and presynaptic plasma membranes). This layered structure
also restricts SNARE zippering and the pins are held at about 2/3 of full assembly.
When the calcium ions arrive and bind Syt1 C2B, the ring disassembles. The geometry of
the C2B domain is such that it needs to rotate by about 90 degrees to allow for the
aliphatic loops to insert into the membrane. This rotation obliterates the ring forming
interface. Simultaneously, C2B domains in both ‘primary’ and ‘tripartite’ sites are
released from the SNAREs and the pins complete the rest of the zippering. This action
puts opposing membranes in close enough proximity to trigger membrane fusion.
Thus, the ring-like arrangement acts as clamp to prevent full SNARE zippering. In
addition, the ring provides calcium-sensitivity necessary for the millisecond speed of
fusion, while simultaneously preventing spontaneous fusion (which is independent of
action potential)32.

2.4.3 Syt1 oligomer clamps fusion
To look at properties of the hypothesized ring-like oligomer, we created an in vitro
system with full control of all components. The minimal machinery of Syt1 and SNAREs
are subjected to physiologically relevant biochemical conditions that are designed to
probe the docking, clamping and fusion of the vesicles. In this method, a continuous
patch of suspended fluid bilayer is composed of 80% POPC, 15% DOPS, 3% PIP2 and
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2% NBD-PE (mole percent) and contains t-SNAREs to mimic the target membrane. The
bilayer is made by bursting t-SNARE containing giant unilamellar vesicles of the above
lipid composition via osmotic shock (in the presence of 5 mM MgCl2).
The synaptic vesicle-like small unilamellar vesicles (v-SUVs) are composed of 88%
POPC, 10% PS and 2% ATTO647-PE and contain about 28 molecules of Syt1 and ~12
copies of Vamp2 facing outward. We employ a “rapid detergent dilution method” to
bring the detergent amount below the critical micellar concentration to allow the
formation of these proteoliposomes. The protein ratios are strictly monitored by
densitometry analyses of SDS-PAGE Coomassie stained gels. An empirically established
protocol calls for input protein to lipid ratios of 1 : 400 for t-SNARE, 1 : 500 for VAMP2
and 1 : 250 for Syt1. This allows us to account for about 50-60% of protein molecules
facing inside the liposomes33.
The overall experimental set up is briefly described below. Diluted v-SUVs are manually
added to a chamber filled with 25 mM HEPES, 140 mM KCl, 1 mM DTT buffer. The
vesicles are allowed to migrate towards the bottom of the chamber, which is lined with a
t-SNARE containing suspended bilayer. The whole process is monitored by a laser
scanning confocal microscope equipped with a 647-nm laser to track the Atto647-PE on
the arriving vesicles. Images are acquired at a 147 milliseconds rate and thus allow for a
detailed examination of the fate of each vesicle.
We present the results as surviving curves that summarize the time each vesicle
‘survives’ sitting on the bilayer without fusion. Visually this is manifested as a
fluorescent particle immobilized (“docked”) on the target membrane. A fusion event is
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classified as a burst and rapid decrease in the fluorescence signal (coming from the
labeled PE diffusing in the target membrane).
To probe the effect of calcium on vesicle fate and to distinguish between evoked and
spontaneous fusion events, a final concentration of 1 mM CaCl2 is added to the top of the
chamber as images continue being collected for 5 mins. Figure 15 was adopted from the
published work done in the Rothman lab and is reproduced here for the reader’s
convenience34.
The ring-disrupting Syt1 F349A mutant was conveniently used here to study the effect of
Syt1 oligomer on vesicle docking, clamping and fusion. The key results are shown in
Figure 16. In summary, the oligomeric assembly of Syt1 is necessary for the clamping.
Vesicles containing no Syt1, or where Syt1’s ability to oligomerize is impaired, do not
survive on the bilayer. Instead they proceed to spontaneously fuse and are not regulated
by calcium. Syt1 WT containing vesicles, however, remain stably clamped for the
duration of observation or until calcium is added.

2.4.4 Concluding remarks
This chapter intended to introduce and summarize key published ideas currently available
in the field. As a graduate student, I was incredibly lucky to be able to contribute to the
discovery and characterization of the ring-disrupting mutant and to learn new techniques
as they were necessary for the project. I was exceptionally fortunate to experience these
discoveries happening in real time and to be part of an incredible group of colleagues.
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Figure 15: Custom experimental set up used for single vesicle analysis.
The bottom of the buffer-filled chamber is lined with a t-SNARE containing bilayer and the 647nm laser on the confocal microscope
is used to track the fluorescence of the vSUVs labelled with Atto-647 PE. The vesicles are allowed to float down and interact with the
t-SNARE bilayer. This part of the experiment probes for vesicle docking and clamping of spontaneous fusion. Addition of external
calcium ions simulates the arrival of action potential and serves as a trigger of evoked fusion. This figure is adopted from FEBS
Letters, Volume: 593, Issue: 2, Pages: 154-162, First published: 20 December 2018, DOI: (10.1002/1873-3468.13317)34
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Figure 16: Syt1 oligomers clamp fusion and synchronize it to calcium.
Representative survival analysis of vesicles containing Vamp2 and WT Syt1, 349A Syt1 and no Syt1 (only Vamp2). Below is the
representation of the observed fluorescence signal. Background fluorescence rapidly rises once all the vesicles start fusing in the
presence of calcium. The Syt1 oligomer is necessary to prevent spontaneous fusion. Data and figure is adapted from the published
work34.
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CHAPTER 3
PHOSPHORYLATION OF SYNAPTOTAGMIN REGULATES
NEUROTRANSMISSION

3.1 Protein Kinase C signaling in the brain (summarizing 50 years of research).
Protein Kinase C (PKC) gene expression is tightly regulated in the brain35. Regionspecific dysregulation of PKC isoforms have been very recently and unequivocally
implicated in severe neurological and mood disorders36. Striking abnormalities in PKC
protein and mRNA expression levels were observed in post-mortem brains of depressed,
suicidal, and bipolar subjects. PKCs are also referred to as “memory kinases” and their
signaling cascades are critical for memory formation and evolving brain circuitry37.
Moreover, altered levels of PKCs are associated with cognitive and memory disorders
such as Alzheimer’s and Parkinson’s diseases38.
The conventional subfamily of PKC isozymes (α, β, and γ) possess tandem C1 domains
(which bind diacylglycerol (DAG) and phosphatidylserine (PS) lipids on the membrane),
followed by a C2 domain (which, as we discussed in the case of Syt proteins are activated
by binding calcium ions and phosphatidylinositol 4,5-bisphosphate (PIP2)). A classical
kinase domain contains a few critical phosphorylation sites which trigger conformational
transitions that stabilize the molecule. The resulting “pre-activated” enzyme is kept in an
autoinhibited form (pseudosubstrate domain occupies the substrate-binding cavity). Once
the C1 and C2 domains are activated by cofactors, the intramolecular bonds break and
release the pseudosubstrate domain. The “open” PKC can now bind and phosphorylate
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substrates35a, 39. This maturation process serves as an additional level of control of PKCdependent phosphorylation40.
The phosphoinositide (PI) signaling system has been shown to link the effect of dynamic
PKC phosphorylation of multiple proteins with critical events in the presynaptic
terminal41. In short, stimulation of Gq-protein-coupled receptors repetitive action
potentials cause the phosphatidylinositol-specific enzyme, Phospholipase C (PLC), to
rapidly hydrolyze membrane lipid PIP2 into two types of second messengers, inositol
1,4,5-trisphosphate (IP3) and 1,2-sn isomer of DAG42. Production of DAG leads to
activation of C1-domain-containing Munc13, which acts as a tether of synaptic vesicles
to the presynaptic plasma membrane43. Translocation of PKC to the inner leaflet of the
neuronal plasma membrane allows for the PKC to interact DAG44. The binding of
calcium molecules fully activates PKC, which in turn, phosphorylates Syt1 and
Munc1845.
Syt1 and Munc18 phosphorylation-dependent signaling events were always thought to
ultimately result in a potentiation of release and short-term plasticity (STP)46. However, a
new report was published this month that looks at the synapses within the hippocampus
and cerebellum. The study indicates that previously identified sites of Munc18 PKCdependent phosphorylation are not the primary mediators of STP47.
The overall role of PKC activity on neurotransmitter release have also been a topic of
debate. Originally PKC was perceived as the calcium sensor for presynaptic STP48.
However, in addition to the subsequent retraction of the paper, another report debunked
this hypothesis49.
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Figure 17: Dysregulation of Protein Kinase C signaling in the brain is implicated in
severe disorders.
A. Cartoon representation of conventional PKC domain architecture. C1 domain is
activated by DG (DAG) and PS, while C2 is Calcium and PIP2-dependent. The figure is
adopted from the recent review of PKC family signaling in the brain35a.
B. General schematic of a PLC-catalyzed hydrolysis of PIP2 into IP3 and DAG.
PIP2 is formed upon phosphorylation of PI in the 4 and 5 positions by PI kinases. GPCR
stimulation then triggers PLC to hydrolyze (i.e., add a water molecule to break a bond)
PIP2 into two second messengers, DAG and IP3. DAG is a hydrophobic, while IP3 is
hydrophilic and serves to stimulate the release of calcium50. The figure was created in
ChemDraw – PerkinElmer Informatics software.
Syt1 phosphorylation by PKC was mapped to a conserved site (Threonine 112) located in
the juxtamembrane linker domain, connecting the TMD and the membrane proximal
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globular domain, C2A45a, 45c, 46b, 51. The study using the non-phosphorylatable mutant
pointed towards this PTM playing a role in STP, yet acting downstream of the vesicle
pool replenishment and priming46b. Even though the C2 domains of Syt1 have always
been thought of as functionally critical, the juxtamembrane linker has also been
implicated in oligomerization and extensive membrane interactions in some older, as well
as very recent works52. The juxtamembrane linker is somewhat conserved in Syt1
isoforms across the phylogenetic tree. It is intrinsically disordered and is comprised of
two oppositely charged motifs. Basic amino acids are abundant in the membrane
proximal N-terminal part of the linker while there is copious amount of acidic amino
acids in the C2A proximal part. These structural features have long intrigued several
groups of scientists53. In addition, phosphorylation of a threonine 112 dramatically
changes the charge distribution and, in theory, may affect the membrane interacting
properties of the linker45c, 54. Given the polyelectrolyte nature of the juxtamembrane
sequence, the sites and effects of PTMs, and the interaction with lipids, it is easy to
imagine that the Syt1 intrinsically disordered linker would have some liquid-liquid phaseseparating properties. Nevertheless, as of now, no work has established this.

3.2.1 Representative literature survey of Syt1 phosphorylation detected in
models in vitro and in vivo
It is critical to point out that Syt1 has been shown to be phosphorylated in different
models in vitro and in vivo. This section summarizes the literature which used different
models and approaches to detect phosphorylation of Syt1. Table 1 also summarizes key
points of this survey.
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The first study came out in 1999 from the lab of Greengard and Czernik. A hybrid
method which involved preparations of isolated, purified, and intact synaptic vesicles
were subjected to in vitro incubation with various exogenous kinases in the presence of
[32P]. Pull-downs were then analyzed and quantified. The relative phosphorylation
abundance was determined to be very low after this treatment. Incubation with exogenous
PKC phosphorylated only ~5% of the total Syt1 present on the vesicles. This is the first
study which attempted to determine the relative abundance of Syt1 phosphorylation on
the intact synaptic vesicles (albeit with exogenously added kinases)45a.
The same report explored the level of phosphorylation in synaptosomes, which consisted
of the presynaptic terminal (including the vesicles) and the postsynaptic membrane45a, 55.
The study established that even though the basal level of phosphorylation was low, Syt1
was being rapidly phosphorylated once PKC was activated (with calcium and a DAG
analog 2)56. Interestingly, the level of phosphorylation of Syt1 was dependent on the

duration of treatment and the concentration of exogenous PDBu (from 20% to 100%
labeling). The stochiometric 100% labelling means that all Syt1 molecules were
phosphorylated with phorbol ester-induced kinase activities, which potentially includes a
contribution from other kinases.
A third attempt at detecting phosphorylation of Syt1 was done in PC12 cells
differentiated under nerve growth factor (NGF) stimulation. These differentiated cells

have been widely used to study properties of sympathetic neurons, which include electric
excitability and neurite extensions24a, 24b. Similar to the protocol with synaptosomes,

Phorbol 12,13-dibutyrate, commonly known as PDBu, is a phorbol ester that is used as
a soluble DAG analogue to activate PKC (and other C1 domain containing proteins, like
Munc13) in vitro and in vivo.
2

49

PC12 cells were treated with PDBu and labelled with [32P]. The authors achieved a
significant ~60% increase in the phosphorylation levels of Syt1 as compared to the basal
level (i.e., before the stimulation of any kinases).
Of note is that all three methods of Syt1 phosphorylation detection mapped the site of
PKC-dependent phosphorylation to the T112 residue discussed above. Another important
detail of this study is that the phospho-residue identification was performed using twodimensional phosphopeptide mapping. In short, digestion with either trypsin or
thermolysin proteases was followed by HPLC purification of the peptides and mass
spectroscopy. Nevertheless, at this time the authors already implied that the PKC
cascades are likely involved in the regulation of synaptic vesicle fusion and the
neurotransmitter release45a, 57.
Soon more phosphoproteomic studies followed suit. For example, in 2005, a
combination of affinity chromatography and mass spectrometry (commonly referred to as
LC-MS/MS or tandem MS) was used to create a map of the mouse synapse
phosphoproteome. The synaptosomes were isolated from mouse forebrains and digested
with trypsin and urea58. This is the first large scale analysis of the in vivo
phosphoproteome59 (laboratory of Grant, S. G). Unfortunately, only two Syt1 peptides
were detected and no phospho-peptides were identified. This is likely because of the
relative low abundance of Syt1 in this sample. Presumably, the same problem resulted in
the low detection of Syt1, as well as no Syt1 phosphopeptide detection from the rat
cerebral cortical synaptosomes. Only one unphosphorylated peptide was detected. The
peptide was mapped to the middle of the C2A60.
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Another proteomics analysis of the post-synaptic density from adult mouse brains yielded
13 peptides covering ~50% of the Syt1 protein. However, no post-translational
modifications on any of the Syt1 peptides were detected. Using a similar tryptic digest
approach, this study came up with an innovating phsopho-peptide enrichment method,
which involved a strong cation exchange chromatography combined with previously used
IMAC (immobilized metal affinity chromatography) and MS/MS. Even though the
sensitivity to Syt1 peptides improved, identification of phosphorylated Syt1 levels and
sites was still not possible61.
A Syt1 specific study using insect cells came out in 2011 from the Brunger laboratory.
The protein was expressed and purified from insect cells, digested with trypsin, and
subjected to LC-MS/MS. Serine 30 and Threonine 128 were identified as being
phosphorylated51.
The 2015 study of the human brain proteome worked with prefrontal cortical regions
from fresh post-mortem brains of clinically diagnosed Alzheimer patients. The lysates
were digested with Lys-C and, using the TiO2 phosphopetide enrichment, subjected to the
LC-MS/MS separation approach. 47 peptides matched Syt1, while 20 peptides contained
phospho-T125 and only one peptide matched with phospho-S264. Also, there were 24
peptides matching with PKCβ2 isoform, 23 of which were phosphorylated. Though
technically it is not exactly appropriate to compare the abundance of phosphorylated vs.
non-phosphorylated peptides from this proteomics methodology62, assuming (unlikely)
equal detection rates, we conclude that Syt1 was approximately 40% phosphorylated 3.
It is extremely important to note that protein phosphorylation stoichiometry analysis
cannot easily be derived from the current phosphoproteomics data. To simply put,
peptides with similar masses but with different charges (a phospho-group adds negative

3

51

Taking a conservative approach, this data from the Peng lab summarized here clearly
shows that Syt1 is, at least to some extent, phosphorylated in the in vivo human brain63.
The summary below is the result of analyzing the proteomics data available in the
supplemental files of the referenced papers or deposited into the Proteomics
Identification Database Archive64. Mining the global analysis of the human brain
proteome and phospho-proteome in Alzheimer’s disease vs. control cohort revealed the
presence of Syt1 phosphorylation on T125 and T128 with an average abundance of 70%.
Isolated tissues from the frontal cortex were digested with trypsin. Phospho-peptides
were enriched with IMAC and subjected to LC-MS/MS. The average level of Syt1
phosphorylation is ~65% (based on the study from the Seyfried lab).65
Another very recent phosphoproteomics report from the R. Jahn lab looked at
synaptosomes prepared from the brains of 5 to 6-week-old rats set out to determine
relative changes in the phospho-proteome upon depolarization and botulinum neurotoxin
treatment. The samples were digested with trypsin and enriched with TiO2 before analysis
by LC-MS/MS. Interestingly, the Syt1 sequence was modestly covered (~15%) and only
one site of phosphorylation was determined (264S). Based on the statistical analysis of
the changes in phosphorylation, this mode of regulation of Syt1 was determined to be
primarily SV-cycling-dependent. Bioinformatics analysis in this study did not map this
site of phosphorylation to the PKC signaling cascade66.

charge to the peptide) migrate differently in the MS. To confirm the extent of
phosphorylation, for example, the western blot phosphospecific antibodies are used to
unambiguously tell the exact abundance of phospho-species as compared to the total
amount of that protein. The key is to have the same detection method for both types of
peptides.
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In a transcriptome and phospho-proteome study that came out just two months ago
(Thacker, S.& Eng, C), Syt1 was clearly shown to be phosphorylated in two-weeks and
six-weeks old mice brains. Interestingly, at two-weeks, the sites of phosphorylation were
mapped to the portion of Syt1 that is facing inside the vesicle cavity (N-terminus of the
Transmembrane Domain). The six-weeks sample, however, mapped the sites of
phosphorylation to the S264 and T128. PKCβ2 was confirmed to be expressed in both
types of samples. The samples were processed with tryptic digest and LC-MS/MS.67

3.2.1.1 Conclusions and limitations of the currently available data sets
Taking these representative studies all together, we see a variety of identified
phosphorylated moieties on Syt1 (S30, T112, T125, T128, S264). Given the differences
in methodologies, it is not surprising that the data is inconsistent. Drastically different
coverages of Syt1 sequence were reported in different studies, which used different
approaches. Since the main goal of these large-scale proteomics studies was to identify
the presence of a particular protein, having even one peptide unambiguously assigned to
Syt1 was sufficient.
For our purposes, however, this is not enough. We are interested in identifying the levels
of phosphorylation of Syt1. A good sequence coverage is imperative to detect all possible
sites of phosphorylation and to accurately estimate the extent of phosphorylation. A PKC
isoform dependent analysis is yet to be made possible.
On that note, we attempted to perform our own proteomics study on purified proteins.
Unfortunately, the data was not satisfactory for our purposes, as the site of interest was
still not properly analyzed. Unfortunately, due the availability of facilities, we were not
yet able to resubmit the samples. However, we hypothesize that treatment with other
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proteases may be of help. The next section takes a closer look at Syt1-specific issues,
which are likely due to commonly used digestion with trypsin.
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Table 1: Key phospho-proteomic studies of PKC-dependent Syt1 phosphorylation.
Literature reviewed in the section above is summarized here in a chronological order. Phosphproteomics data spans two decades and is
derived from insect, mouse, rat and human cells. Peptide digestion is limited to trypsin, thermolysin, and Lys-C. Studies mostly have a
modest detection and coverage of Syt1 and phosphorylated Syt1 peptides.

Organism

Sample

Digestion

preparation

method

Phosphoproteomics
method (relevant to Syt1

Senior author (s),
Relevant result summary

and PKC cascades)

and reference

Stripping for baseline and
Rat forebrain

Purified

Trypsin and

in vitro kinase addition

5% PKC-dependent

vesicles

thermolysin

and specific activation of

phopshorylation

PKC

Rat forebrain

Isolated

Trypsin and

synaptosomes

thermolysin

Stripping for baseline and
in vitro kinase addition
specific activation of PKC
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publication year

20 – 100% PKC-dependent
phosphorylation (variability
based on kinase activation
and treatment duration)

Greengard, P.;
Czernik, A. J
199945a

Greengard, P.;
Czernik, A. J
199945a

Rat forebrain

NGF-treated

Trypsin and

PC12 cells

thermolysin

Insect cells (fruit

Purified insect

fly)

Syt1

Trypsin

Exogenous stimulation of
endogenous PKC with
PDBu

Whole brain

diagnosed

extract

Syt1

199945a

Syt1 phosphorylation is

Brunger, A.T

enrichment

detected

201151

Syt1 is 43% phosphorylated
Lys-C

Czernik, A.J

LC-MS/MS, no

Human brain
(control and

63% phosphorylation of

Greengard, P.;

TiO2, LC-MS/MS

(yet not only specifically by
PKC)

Alzheimer’s)

Peng, J
201563

Human brain
(control and

Whole brain

diagnosed

extract

Trypsin

TiO2, LC-MS/MS

Trypsin

TiO2, LC-MS/MS

Syt1 65% phosphorylated

Seyfried, N. T.

(not PKC specific)

202065

Syt1 phosphorylation is

Jahn, R.

detected

202166

Alzheimer’s)
Rat brain

Whole brain
extract
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Mouse brain

Whole brain
extract

Trypsin

TiO2, LC-MS/MS
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Syt1 phosphorylation is
detected

Thacker, S & Eng,
C.
202167

3.2.1.2 Digestion with different proteases may improve the sequence coverage
As summarized in Table 1, three types of proteases were used in the literature: trypsin,
Lys-C and a trypsin/thermolysin combination. To estimate theoretical sequence coverage
with these enzymes, we performed a simple in silico analysis of potential cleavage sites.
Given a protein sequence, PeptideCutter server calculates the possible cleavage sites
based on the properties of the selected protease68. Thus, we performed the analysis for
trypsin and Lys-C. Trypsin is known to cut the bond at the carboxyl group of either
arginine or lysine. Lys-C cleaves at the C-terminus of only a lysine residue. The full
sequence results are included in the supplement in Figure 20 (Appendix C, page 82).
Typically, very small and very large peptides are difficult to detect in the mass
spectrometric spectra. These peptides do not show up in the final analysis and, thus, will
be missing from the coverage69. Brief analysis of the Syt1 sequence very clearly shows
that polybasic-rich regions of Syt1 will be too small (i.e., the sequence is cut at the Cterminus of every lysine and arginine). Thus, the lysine-reach reach region of the linker
(amino acid 80 – 91 and possibly others), and the polybasic sites on C2A (188 – 192) and
on C2B (~320 – 332) will not show up on the spectra. Moreover, any posttranslational
modifications in these regions will not be determined. To carefully sequence these
missing regions, a specifically designed mixture of proteases will need to be used.

3.2.2 Significance and rationale of the project
Even though incredible progress has been made over the past 30 years, there is still no
precise molecular-level understanding of the effect of Syt1 phosphorylation on its
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function, the role of PKC in neurons and the mechanism of STP. To date, the following
statements can be made:
•

Syt1 is expressed in the brain and is phosphorylated.

•

Levels and locations of phosphorylation are variable (likely due to the
difference in the detection methods).

•

Protein kinase C, among many signaling cascades, is implicated in
phosphorylating Syt1.

•

PKC-dependent phosphorylation may play a role in vesicle recycling
and synaptic plasticity.

Given our unique expertise with in vitro vesicle reconstitution and a readily available set
up of the single vesicle assay (described on page 40), we set out to see how PKCdependent phosphorylation of the full cytosolic domain of Syt1 (54-421) would affect the
docking, clamping, and fusion of a vesicle.

3.2 In vitro phosphorylation of Syt1 by PKC beta 2
Building upon the previously established protocol for synaptic vesicle reconstitution, I
augmented the procedure to allow for a phosphorylation (and subsequent dephosphorylation as a “rescue” control) by PKC β2 (the protocol was previously described
in section 2.4.3). In short, synaptic-like vesicles consisting of 84% PC, 15% PS, and 1%
Atto647-PE were reconstituted with ~24 copies of Synaptotagmin and ~12 copies of
Vamp2. Vesicles were dialyzed overnight and subjected to centrifugation in a
discontinuous density gradient. The vesicles were mixed into a Nycodenz® 40%
solution, then layered with 30%, followed by a buffer on top. After four hours of
centrifugation at a speed of 50,000 rpm in an SW55 swinging-bucket rotor, a blue band
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corresponding to an Atto647-labeled liposomes was collected from the buffer layer. This
step allows for a separation of proteo-liposomes from free proteins and other aggregates.
The collected liposome sample was split into two equal parts. One part (“phosphorylated”
sample) was incubated with PKC β2 and cofactors 4 for 1 hour at 32 oC, while the other

(“control” sample) was subjected to identical conditions except the enzyme was omitted
and the volume was substituted with a sample buffer. Then, the samples were again
subjected to a flotation in a density gradient (2nd round) and blue bands were
subsequently collected from the buffer layer. This procedure is outlined in Figure 18. To
perform the phosphatase 5 “rescue” experiment, the “control” and the “phospho” samples

were again split and subjected to a de-phosphorylation reaction: incubate with λ-

phosphatase for 1 hour at 32 oC and then perform a third round of a discontinuous
gradient flotation for 4 hours. Collected vesicles (vSUVs) with Syt1WT, Syt1pWT and
Syt1ΔpWT were used in the single vesicle experiments shown in Figure 20.
To verify that the kinase and the phosphatase are active, and the reaction conditions are
optimal, I adapted the vesicle phosphorylation protocol to work with a radioactive P-32

Typical reaction mixture consisted of the following components. Kinase, ~20 nM
PKCβ2, was resuspended in kinase buffer (20 mM HEPEs, pH=7.25, 5 mM MgCl2, 5
mM MnCl2, 3% glycerol, 40 mM NaCl) and supplemented with 1 mM DTT, 1 mM
sodium orthovanadate, kinase activator (0.05mg/ml phosphatidylserine and 0.005 mg/ml
diacylglycerol as water soluble analogues and glycerol 2-phosphate for an additional
phosphatase inhibition), 100 µM CaCl2. 10 uM ATP was added to the mixture. The cold
ATP was spiked with 0.75 µCi of [γ-32P]-labeled ATP. Active recombinant PKC enzyme
(14-496 Sigma-Aldrich) and PKC activator (20-133 Sigma-Aldrich) mixtures were
purchased from Millipore Sigma. Ultra-pure ATP was purchased from Thermofisher
(R0441) and the radioactive ATP was from Perkin Elmer with catalog # NC1639816.
Other generic chemicals were purchased from Thermofisher and CHEM-IMPEX.
4

Phosphatase reaction consisted of 200 nM Lambda phosphatase in the presence of 5
mM MnCl2, 20 mM HEPEs, pH=7.25, 5 mM MgCl2, 40 mM NaCl).

5
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isotope. Syt1WT-containing vesicles were incubated with the kinase and the cofactors in
the same conditions, while the ATP was spiked with radioactive [γ-32P]-labeled ATP.
Upon the reaction completion, the sample was separated on an SDS-PAGE gel 6 and the

fixed samples were exposed to the phospho-screen over night or were analyzed with the
scintillation counter. The resulting image clearly shows the presence of a phosphate
group on the Syt1 (Syt1pWT). Note that there is no phospho-group present on the Vamp2

protein suggesting that it is “immune” to phosphorylation by PKC β2 (Figure 19).
According to the protocol established earlier in the lab and outlined in Chapter 2, the
vesicles were deposited into the chamber filled with a 1x buffer (1 mM magnesium
chloride)70. The bottom of the chamber, which is made from a silicon chip with 5 µM
holes, was covered with a supported lipid bilayer. Briefly, the liposomes consisting of
79% PC, 15% PS, 5% PIP2 and 1% NBD-PE were reconstituted with a 5x buffer and
dialyzed overnight. The liposomes were then dried on a surface and allowed to swell up
with water, forming GUVs. The GUVs were then deposited on the pre-cleaned (plasma
cleaner) chip surface. The 5 mM magnesium chloride buffer burst the GUVs on the
surface and provided a coating across the chip surface. Supported lipid bilayer spanning
at least a patch of 8x8 holes was tracked in the experiment. The cumulative docking-tofusion delays are shown in Figure 20. All SUVs in the experiment contain 12 copies of
VAMP2, which is monitored by the SDS-PAGE and input/output densitometry analysis.
As expected, the SUVs containing control Syt1WT docked to the surface and remained
docked for the duration of the experiment or until 1 mM of calcium ions was added

This separation procedure was chosen as a poor man’s separation option to substitute
for the float up protocol. The swinging bucket rotor need for the discontinuous density
float up was not adapted to the work with [γ-32P]-labeled ATP.

6
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(calcium addition is not shown in the figure)70a. To the contrary, vesicles that were
subjected to the phosphorylation treatment with PKC β2 (Syt1pWT) exhibit a drastically
reduced clamping ability. Tracking the vesicles approaching and interacting with the
bilayer in real time, we observed a curious behavior. Syt1pWT-containing vesicles
approach the surface, “dance” around as if exploring the bilayer and then spontaneously
fuse after an average of 1.5 seconds. Fusion happens without the addition of calcium.
This is in stark contrast to the vesicles containing WT Syt1, where the vesicles dock and
are visually immobilized on the bilayer. This strongly suggests that the phosphorylation
of Syt1 affects the clamping ability of Synaptotagmin and does not prevent spontaneous
fusion. Interestingly, the treatment with a phosphatase, which removes the phosphogroups from the serine and threonine amino acids on Synaptotagmin (Syt1ΔWT), partially
rescued the clamping behavior and prevented spontaneous fusion 7. The fact that the

rescue is not complete is likely due to the suboptimal de-phosphorylation conditions.
However, this reversibility strongly suggests that the drastic lack of clamping ability

observed in the Syt1pWT sample is due to phosphorylation. Based on this result, we
conclude that phosphorylation of Syt1 prevents vesicles from clamping and leads to an
increase in spontaneous fusion.

Given that this was intended as a control experiment to show reversibility of the
phosphorylation, we used lambda phosphatase kinase which is active towards
phosphorylated serine, threonine, and tyrosine residues. Removal of the phosphate was
determined using the [γ-32P]-labeled ATP incorporation rate and visualized on the SDSPAGE. Please refer to the (radiogram is shown in Figure 16, APPENDIX C).

7
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Figure 18: Adapted vesicle reconstitution and phosphorylation protocol.
Syt1 (24 copies) and Vamp2 (12 copies) were reconstituted with DOPC and DOPS containing lipids. Upon reconstitution, the vesicles
were subjected to a density gradient centrifugation. Clarified small unilamellar vesicles (SUVs) were either treated with PKCβ2 and
cofactors or identically but excluding the kinase. Upon the second round of density gradient centrifugation, two samples were
collected. Phospho-SUV-Syt1pWT (vesicles with phosphorylated Syt1) and control SUV-Syt1WT (control vesicles with untreated Syt1).
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Figure 19: Syt1 reconstituted into vSUVs is phosphorylated.
Control vesicles SUV-Syt1WT were run on a 12% SDS-PAGE and Coomassie-stained. Protein densities corresponding to Syt1WT (~43
kDa) and Vamp2 (~17 kDa) are labeled. Concentration and densitometry analysis confirms that the protein composition is ~24 copies
of Syt1 to 12 copies of Vamp2. The vesicles are treated with 20 nM kinase (PKCβ2), cofactors (DAG, PS, and calcium) and [γ-32P]labeled ATP for 1 hour at 32 oC. The sample is then run on the 10% SDS-PAGE and the radioactivity is collected either on the
phosphoscreen or detected with a scintillation counter. Here, the digital image was obtained by exposing the phosphoscreen to the
laser-induced stimulation. The radiolabel was detected on the kinase (autophosphorylation, denoted as PKCpβ2), on the Syt1
(Syt1pWT), but not on Vamp2.
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Figure 20: Cumulative docking-to-fusion delays.
The time between docking and fusion of each vesicle is measured and the data is
presented as a survival curve. Control vesicles contain ~12 copies of VAMP2 and ~24
copies of wild-type Syt1 (Syt1WT); same vesicles phosphorylated with PKC β2 (Syt1pWT);
Syt1pWT vesicles subsequently treated with a phosphatase (Syt1ΔpWT) were analyzed.
Vesicles containing Syt1WT and phosphorylated Syt1 (Syt1pWT) were tested multiple times
(four biological replicates of vesicles and six different preparations of pore-spanning
bilayer.) Dephosphorylated sample (Syt1ΔpWT) was measured only once (phosphatase
treatment radiogram is shown in APPENDIX C, Figure 30).
3.3 Site of phosphorylation
As the next step we set out to understand the molecular mechanism by which Syt1
phosphorylation would cause such a dramatic effect in spontaneous fusion. One of the
previously identified group of sites (T112, T125, T128)71,16, 46b which is referred to as
“T112/125/128” in this work, is located in the juxtamembrane linker connecting the
tandem C2 domains with the transmembrane domain. However, upon mutating the site
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(i.e., substituting threonine residues with alanine: T112/125/128A) and attempting to
phosphorylate the Syt1, we observed only a modest decrease in the overall
phosphorylation level (Figure 21). This suggested that there were other sites of
phosphorylation present on the molecule of Syt1. It is also important to note that up until
this work, the field was not focusing on differentiating between different PKC isoforms.
Even the most notable recent works simply used a cocktail of PKC isoforms, which
would often be extracted from the brain. For example, the most recent work used a
commercially available sample purified from the rat brain, which consisted of α, β and γ
with lesser amounts of δ and ζ isoforms (PKC, Promega, V526A)72. However, as more
work is being done on the cell types other than neurons, it becomes evident that different
isoforms of PKC are not simply functionally redundant. For example, different isoforms
of PKC have been found to be activated by different adaptor proteins73; PKCβ2 is
particularly important in the regulation of ceramide metabolism74, the isoform is also
implicated in the activation of PI4 kinase in cardiac myocytes and oocytes, which is
likely responsible for the mechanism by which membrane depolarization increases PIP2
levels75. Another interesting observation in the oocytes suggests that only PKCβ2 and
PKCε isozymes regulate the function of voltage-gated calcium channels76.
Going back to the discussion of liquid chromatography and tandem mass spectrometry
analyses – which often employ trypsin digestion of the proteins to create smaller peptides
– these putative sites of phosphorylation will not be possible to identify in vivo. As
previously mentioned, peptides that are too small (below 350 kDa or ~4 amino acids) are
often missed in the spectrum and are excluded from the analysis. When lysine residues
are located next to each other, as they are in the polybasic patch of C2B, the region of
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interest becomes virtually impossible to analyze for post-translational modifications.
Critically, the region of interest was not detected in my own purified sample of rat Syt1
(96-421). The sequence was not covered from arginine 322 to lysine 331
(RLKKKKTTIK). Thus, a routine LC-MS/MS analysis was not suitable for the study of
post-translational modifications on T328/329 (the spectra and analysis are not included
here but are available upon request).
Thus, as the last resort (and given that we were working from home during the
pandemic), we launched a bioinformatics-informed investigation of putative sites of
phosphorylation, which would be specific to the PKCβ2 isoform. Together with
Keerthana Chari, an exceptionally bright and hard-working high school student intern
(summer of 2019 and 2020), we designed, performed, and analyzed an extensive threedimensional in silico search, which allowed us to score putative sites of phosphorylation
based on (1) the sequence conservation among different organisms along the
phylogenetic tree, (2) sequence conservation along the Synaptotagmin family axis, and
(3) based on the consensus sequence specific for PKC family and, particularly, the β2
isoform. The overall data was then fed into several machine learning algorithms available
online. A representative data is shown in Figure 22, where the putative sites of
phosphorylation are scored according to their probability of being phosphorylated by
PKC β2. It is immediately evident that there are several sites of phosphorylation that
could have been previously missed. Listed in the order of decreasing probability of
phosphorylation, two locations on C2B domain (T328/329 and S279) and two amino
acids in C2A domain (T195, 211) scored high. Interestingly, previously identified sites in
the linker domain (T112, 125, 128) scored low, which is in support of the data showed in
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Figure 21. Looking at the spatial arrangement of the predicted putative sites of
phosphorylation (Figure 23), it becomes evident that the T328/329 site in the C2B
domain may be implicated in the functional effect observed in the single vesicle assay.
T328/329 are located right next to the polybasic site (K324-327), which is critical for
interacting with the plasma membrane. It is easy to imagine that an addition of a bulky
negatively charged group next to the positively charged lysine stretch would impair
efficient electrostatic interactions with the negatively charged lipids in the plasma
membrane (DOPS/PIP2). In addition, the literature survey suggested that the homologous
site of phosphorylation by PKCβ2 was previously established in the Syt6 isoform.
Moreover, the study also observed a functional effect of that phosphorylation on
exocytosis in sperm71, 77.
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Figure 21: Alanine mutant of T112, 125, 128 on Syt1 reduces phosphorylation, but
does not abolish.
(3) γ-32P radiogram of Syt1WT and Syt1T112/125/128A treated with γ-32P labeled ATP and
PKCβ2 under conditions specified on page 59. Autophosphorylation of the kinase
is used as a loading control and a scaling factor for the level of phosphorylation
of Syt1WT and Syt1 T112/125/128A.(B) Representative P-32 radiograph was analyzed
three times in ImageJ and the normalized densitometry ratios of Syt1p/PKCp are
shown. Given only a slight decrease in the amount of phosphorylation of Syt1
T112/125/128A
as compared to Syt1WT, we conclude that there must be other putative
sites of phosphorylation.
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Figure 22: Probability of phosphorylation of rat Syt1 threonine (blue) and serine
(red) residues by PKCβ2.
Syt1 rat sequence (UniprotID: P21707) was submitted into the following servers:
NetPhos 3.116 and NetworKIN17. Firstly, results were selected for any PKC isofrm and
ranked according to the probability of occurrence (summarized above). The results were
further subclassified for PKC isoforms and ranked. Importantly, T125, 128 and T329
scored higher for the PKCα isofrm, while the other labeled sites (T112, T195, 211, S279
and T328) scored the highest for the β. The results were further verified with NetPhospan
server (which is based on convolutional neural networks)18 and the highest probability
hits for PKCβ are the peptides containing the threonines in position 328 and 329.
Remarkably, the T328/329 site on Syt1 is very strongly evolutionary conserved along the
phylogenetic tree and across the family of Synaptotagmin isoforms (Figure 24). This is
consistent with the observation that phosphorylated threonine and serine residues are
more evolutionary conserved than non-phosphorylated T and S residues76. Thus, given
the strong sequence conservation, previous functional significance of the phosphorylation
site in Syt6 and proximity to the key functional area in the C2B domain, we set out to
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investigate this putative site in detail. We created a mutant where the putative site of
phosphorylation T328/329 and the previously identified site on the juxtamembrane linker
domain (T112/125/128) were mutated and substituted with an alanine (this mutant is
denoted as Syt15A). Spatial arrangement of the key sites in relation to the plasma and the
vesicle membrane is shown in Figure 25. Remarkably, PKCβ2 phosphorylation of this
quintuple alanine mutation, Syt1p5A, was almost completely abolished (Figure 26).

Figure 23: Potentially phosphorylated residues on C2A and C2B
PDBID: 5CCG, chain E (Syt) was visualized in Chimera 19. Polybasic site on C2A
domain (K189-192) faces in the opposite direction from the putative phosphorylation
sites (T211/T195). The putative phosphorylation site in the C2B domain (T328/329) is
located in the middle of the as the polybasic stretch on C2B domain (K324-327, and other
proximal posoitively charged residues: K331-332). Also, S279 on the C2B domain is
seemingly facing in the opposite direction from the membrane binding site. However, a
closer look suggests the site may be important in a SNARE interaction (See APPENDIX
C, Figure 16 for discussion).
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Figure 24: Polybasic patch and putatively phosphorylatable threonines (328, 329) in
C2B are highly conserved.
Threonine in the position of 328 is absolutely conserved across the species, threonine 329
is mutated to a serine (also theoretically phosphorilatable by PKC) in fly and worm.
Across all Syt1 isoforms threonine in 328 is conserved, while the second threoinine (329)
is only conserved in several isoforms.
Phylogenetic analysis across different species: Syt1 sequences from a fruit fly (UniProt
ID: P21521), worm (Q9BI78), human (P21579), rat (P21707), zebrafish (Q6DGI9),
alligator (A0A1U7RVS2) were put into Clustal Omega sequence alignment program 20.
Similar method was used for the alignment of all Syt isoforms for the human (Syt1:
P21579; Syt2: Q8N9I0; Syt3: Q9BQG1; Syt4: Q9H2B2; Syt5: O00445; Syt6: Q5T7P8;
Syt7: O43581; Syt8: Q8NBV8; Syt9: Q86SS6; Syt10: Q6XYQ8; Syt11: Q9BT88;
Syt12: Q8IV01; Syt13: Q7L8C5; Syt14: Q8NB59; Syt15: Q9BQS2; Syt16: Q17RD7;
Syt17: Q9BSW7)
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Figure 25: Location of putative phosphorylation sites relative to the vesicular and
plasma membranes.
Schematically represented Syt1 C2 domains connected to a synaptic vesicle membrane
via the juxtamembrane linker and the transmembrane domain. Plasma membrane is
schematically shown to have PIP2 clusters (black). The putative phosphorylation site
(T328/329) is located next to the polylisine patch (K324-327), which is responsible for
the interaction with the membrane negatively charged lipids. Additional bulky negative
charge which may be the result of the phosphate transfer is expected to create
electrostatic clashes and steric hindrance. Another site of phosphorylation
(T112/125/128) is on the justamembrane linker and it has been previously implicated in
the PKC-dependent modulation of Syt1 function8. In this work, we generated the
phosphomimetic Syt1 mutant, where both threonines in the C2B site were mutated into a
glutamic acid, T328/329E, referred to as Syt1T328/329E. The “non-phosphorylatable”
alanine mutants had the threonines mutated to alanines: T112/125/128A is termed
Syt1T112/125/128A; T328/329A is Syt1T328/329A; and the mutant with both sites mutated to
alanine, T112/125/128/328/329A is Syt15A. In vitro phosphorylated proteins (for
example, in Figure 8) is referred to by a subscript “p” (e.g. Syt1p5A).
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Figure 26: Mutation of all five putatively phosphorylated threonines to alanines
drastically reduces overall phosphorylation of Syt1.
Γ-32P radiogram of Syt1WT and Syt15A treated with γ-32P labeled ATP and PKCβ2 under
activating conditions specified in section 3.2. Autophosphorylation of the kinase is used
as a loading control. Keeping the cofactors and the concentration of PKCβ2 constant in
each reaction (20 nM), serial dilutions of Syt1WT and Syt15A were tested (10 µM to 0.63
µM). While it is evident that phosphorylation of the WT (Syt1pWT) is concentration
dependent, five-alanine mutant (Syt15A) abolishes phosphorylation under the same
conditions. For a more detailed study of the Syt1 phosphorylation reaction by PKCβ2,
please refer to Figure 17 in APPENDIX C.
3.4 Phosphomimetic mutant of Syt1
To further investigate the importance of the putative phosphorylation site, we generated a
phosphomimetic mutation (tandem threonine to glutamate) T328/329E (structural change
and charge distribution is shown on page 75). The mutant is referred as Syt1T328/329E here.
This mutant is designed to mimic the presence of a phosphorylation group on both sites,
and 100% of the time. As shown in Figure 27, the vesicles containing the Syt1T328/329E
mutant exhibited a profound effect. The clamping ability of these vesicles was abolished,
and the vesicles survived for an average of one second before proceeding to
spontaneously fuse. This effect is even more dramatic than the original Syt1pWT. This is
likely because Syt1WT was not 100% phosphorylated when subjected to the in vitro
reaction with PKCβ2. To establish the importance of the C2B site even further, we tested
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the clamping ability of the alanine mutants. Substitution of threonine with alanine
prevents the kinase from phosphorylating the Syt1 molecule at the site of mutation
(Figure 26). The C2B site alanine mutant, T328/329A, was purified and incorporated into
the vesicles containing 12 copies of Vamp2, as it was described in the general protocol.
The vesicles were similarly subjected to the same protocol of phosphorylation with
PKCβ2 under the same conditions and the resulting phosphorylated vesicles were tested
in the single vesicle assay (Figure 27: Syt1pT328/329A). As expected, the vesicles were able
to clamp, albeit not at the SytWT levels (~3s docking to fusion delay, while the WT Syt1
containing vesicles would not fuse until calcium was added). Vesicles containing the
cumulative alanine mutant (Figure 27: Syt1p5A), resisted the effect of phosphorylation
even further. Their clamping was further improved up to ~4.5s. Given that these
experiments have only been performed a modest number of times, multiple biological
repeats are necessary to understand why the clamping ability was not fully restored. One
simple preliminary speculation is that the effect is due to the contribution of another site
of phosphorylation (likely either S279, or T195/T211). As we saw in Figure 26, blocking
all five putative threonines with alanines drastically reduced the phosphorylation, albeit it
did not abolish it completely.
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3.5 Hypothetical mechanism of control
Taking these results together, we arrive at an elegant conclusion that phosphorylation of
Syt1 may act as a toggle switch turning the Syt1 clamp “on” or “off”. Moreover, this
switch is likely very tightly regulated given the precision with which the levels of the
PKCβ2 kinase are regulated in the presynaptic terminal.

Figure 27: Cumulative docking-to-fusion delays of vesicles containing ~12 copies of
VAMP2 and ~24 copies of synaptotagmin mutants.
The time between docking and fusion of each vesicle is measured and the data is
presented as a survival curve. Incorporation of the phosphomimetic of Syt1 (Syt1T328/329E)
abolishes vesicle clamping. Phospho-resistant mutants (which were treated with the
kinase and cofactors under the previously described conditions), Syt1T328/329A and Syt15A,
efficiently restore the clamping ability albeit not completely. We believe there may be a
slight contribution from other phosphorylation sites on the C2A and/or S279.
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Since the clamping mechanism is thought to regulate evoked exocytosis, phosphorylation
of Syt1 and a de facto decoupling of the clamp from the calcium levels and action
potential may be used to regulate the balance between types of release. These and further
physiological hypotheses need to be studied in cell-like environments.

3.5.1 Immediate goals and future directions
Currently, we established a collaboration with the group of Dr. Erdem Karatekin who is
looking at the implications of Syt1 phosphorylation mutants in the BON cell model.
Preliminary studies suggest that the expression of a non-phophorylatable Syt1 mutant
may cause a drastic decrease in evoked release (which is compatible with the observed in
vitro results in a sense that there are no vesicles left to clamp and release with calcium).
However, the precise mechanism of this effect is yet to be established. One important, but
not yet tested question is whether vesicle docking and the readily releasable pool size is
affected by phosphorylation. By reconstituting SUVs with a Vamp4x 8 mutant in our in
vitro set up, we can arrest the clamp in the non-fusogenic state because the Vamp4x
mutant does not allow for the full zippering of the SNARE complex22, 78.
In addition, we plan to look at the synaptic morphology in neuronal cultures. Thin slices
of frozen cells will be stained with uranyl acetate for contrast and imaged by EM. The
number of docking vesicles will then be counted and compared between neurons
possessing Syt1WT or a phosphorylation mutant79. To conclude, we believe that we may
have discovered a molecular mechanism of in situ regulation of Syt-mediated vesicle

A VAMP2 mutant with C‐terminal half modifications (L70D, A74R, A81D & L84D)
does not allow for a complete zippering of the SNARE complex. The mutant is termed
VAMP2‐4X.
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release, which may be employed by neurons to confer an additional level of control.
Intricate molecular co-dependencies are likely central to this process. Interplay between
lipid metabolism, production of second messengers, binding of Syt1 and PKC to the same
lipids (same C2 domain folds), yet different calcium sensitivities are likely tightly
regulated to maintain precise equilibrium between spontaneous and calcium evoked
neurotransmitter release.
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APPENDIX B

Figure 28: Native Mass Spectrometric analysis of a WT Syt7 C2AB domain (143 -421).
Only a dimer and possibly a tetramer were detected above the noise level. The purified protein was incubated with oligomer-triggering buffer
(1 mM of ATP), exchanged into 20 mM ammonium acetate and 1 mM DTT, and sprayed on the mass spectrometer. This experiment was
performed in the laboratory of Kallol Gupta at Yale Nanobiology Institute in collaboration with Dr. Fabian Giska and Dr. Aniruddha Panda.
Native MS was performed on Q Exactive UHMR mass spectrometer (Thermo Fisher Scientific) using in-house nano ion-emitting capillaries.
The ultrahigh vacuum of 5.65 × 10−10 mbar, capillary voltage 1.5 kV, optimal insourcce trapping and HCD were used.
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Figure 29: Native Mass Spectrometric analysis of a Syt1: Syt7 C2AB domain mixtures (50:50 mole percent).
Note how a hybrid dimer and trimer (trimer – assignment not shown but is available upon request) is more abundant than the
homodimers. The purified protein was incubated with oligomer-triggering buffer (1 mM of ATP), exchanged into 20 mM ammonium
acetate and 1 mM DTT, and sprayed on the mass spectrometer. This experiment was performed in the laboratory of Kallol Gupta at
Yale Nanobiology Institute in collaboration with Dr. Fabian Giska and Dr. Aniruddha Panda. Native MS was performed on Q
Exactive UHMR mass spectrometer (Thermo Fisher Scientific) using in-house nano ion-emitting capillaries. The ultrahigh vacuum of
5.65 × 10−10 mbar, capillary voltage 1.5 kV, optimal insourcce trapping and HCD were used.
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APPENDIX C

Figure 30: Treatment of phosphorylated vesicles with λ-phosphatase phosphatase
removes close to 95% of phosphorylation from both Syt1 and PKC.
This is a radiography (P-32) analysis of Syt1 de-phosphorylation. Lambda phosphatase
causes a significant reduction in P-32 signal (95%), while the addition of calcineurin has
less effect (~50%). We used the λ-phosphatase in the single-vesicle assay for the “rescue”
experiment (Syt1ΔWT). Calcineurin is another phosphatase, which is calcium and
calmodulin dependent and is specific towards serine and threonine residues. It is present
in the brain and its dysregulation is implicated in neurological disorders. Even though this
phosphatase decreased the amount of phosphorylation, the effect was not as drastic. This
is likely due to suboptimal calcium/calmodulin conditions. Since this was meant as a
rescue control experiment, we used λ-phosphatase in the single-vesicle assay.
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Figure 31: T329 and T201 sites of phosphorylation may be specific for the low
affinity calcium sensors.
This is a simplified diagram of the conservation of sites of phosphorylation augmenting
Figure 11. Syt1, Syt2 and Syt9 are low affinity calcium sensors and are critical for the
fast synchromous release. T329 and T201 sites of phosphorylation are missing in Syt7
and a closely related Doc2b.
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Figure 32: Syt1 S279 points into the primary SNARE interface.
PDB ID 5CCG was visualized in Chimera and S279 in Syt1 (red sphere representation)
was mutated to a glutamate (E279) to mimic an addition of the phosphorylation group. A
larger overall size and an additional negative charge wilikely create clashes in the
primary site. Other residues identified as critical charge-charge interactions for the
primary Syt1-SNARE binding site are labeled and color coded. SNAP25 in green,
Syntaxin in red, Synaptotagmin in pink/magenta and S279 in red. F349 in Syt1 is labeled
in black and is perpendicular to the plane of the view.
It is important to note that even though this site of phosphorylation may be functionally
important and may play a role in the SNARE binding properties, we have not performed
any in vitro studies targeting this site. However, the SNARE interactions will be
thoroughly checked as a control.
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Figure 33: Phosphorylation of Syt1 follows the Michaelis-Menten kinetics.
Increasing concetration os Syt1WT were titrated against constant amounts of 10 nM
PKCβ2 and cofactors. The levels of phosphorylation were read in the scintillation counter
and plotted against the concetration of Syt1. Fitting the data points with the MichaelisMenten kinetics curve produced KM and kcat constants. The affinity of the enzyme to the
substrate is fair (as compared to other previously identified PKC substrates21–24), which is
indicated by the Michaelis constant, KM, which is in the micromolar range.
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Figure 34: Theoretical peptides resulting from Syt1 digested with LysC and trypsin.
Canonical Syt1 rat sequence (UniProt ID: P21707) was subjected to in silico digestion predicted with ExPASY PeptideCutter server68b. LysC and
trypsin are predicted to cut the sequence at the indicated positions on the right (C-terminal) side of the labeled amino acid. For example, the first
peptide resulting from the LysC and trypsin digestions has the sequence of MVSASHPEALAAPVTTVATLVPHNATEPASPGEGK. The algorithm
for trypsin includes probabilities of the cleavage at each site.
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